SRX Global Inks Stock Purchase Agreement With Cero Therapeutics; To Acquire All Outstanding Stock Of Cero Therapeutics

SRX Global has entered into a stock purchase agreement to acquire all outstanding shares of Cero Therapeutics. This strategic move aims to enhance SRX Global's portfolio and market presence. The financial terms of the acquisition were not disclosed in the announcement.